Sign In  
  Sign Up  
  Popular - Categories
  Popular - All Uploads
  Recent - Categories
  Recent - All Uploads
  Random Upload
  Contact NewTube  
About NewTube  
  Support NewTube
Sourced of - https://tobyrogers.substack.com/p/breaking-newly-released-documents?r=137syk&s=r ALL E-MAIL ADDRESSES LISTED ON SUBSTACK - SECTION IV. https://www.regulations.gov/document/FDA-2022-N-0905-0001 👈 Complain Form We only have about 24 hours to act so let’s leave it all on the field! Please submit a formal comment to the regulations.gov website stating that the FDA must reject the “Future Framework” and that all reformulated Covid-19 shots must go through proper human clinical trials. The docket number is FDA-2022-N-0905. The docket will close Monday night June 27, 2022 at 11:59 eastern time. Click (here) to go to the relevant page on the regulations.gov website and look for the blue comment button in the upper left hand corner. The FDA lies about the number of comments submitted but we have a lawsuit going about that so the more comments we can submit (that they will subsequently hide) the better for our case. In addition, here are the email addresses for everyone at the FDA/VRBPAC who has a say in this matter. It is our right to share with them our thoughts and concerns about this process. You can share your own story or copy and paste the message below. Subject line: All reformulated Covid-19 shots MUST go through proper clinical trials The safety and efficacy of all reformulated Covid-19 shots must be evaluated through: • Large (50,000+ person) double-blind randomized controlled trials with inert saline placebos conducted by an independent third party. • The treatment and control groups must be followed for life to monitor adverse events and all-cause mortality (no more wiping out the control group after 6 months to hide bad outcomes). • We also demand greater than 90% efficacy against infection with less than 0.1% Grade 3 or higher adverse events; proper monitoring for carcinogenesis, mutagenesis, and impairment of fertility; and immediate release to the public of all clinical trial documents submitted to the FDA.
Category: News
No Comments Yet